WO/2016/168881 DEVICE FOR DELAYING INTRODUCTION OF AGENTS TO A CISTERN||WO||27.10.2016|
||PCT/AU2015/000246||BRITZ, Howard Oliver||BRITZ, Howard Oliver|
A refillable, stand-alone in-cistern device that is activated only by the rising and falling of the water in the cistern that will delay the introduction of a concentrated dose of liquid cleansing agent into the last part of the flush cycle of the toilet, thereby delivering a wide range of improved cleaning and deodorising consumer benefits. The invention only requires securement in any convenient position inside the cistern wall and requires no other customer installation maintenance.
WO/2016/168882 STATISTICAL METHOD FOR MICRO-SCALE ROCK DAMAGE QUANTIFICATION AND CHARACTERISATION USING X-RAY MICRO-TOMOGRAPHY||WO||27.10.2016|
||PCT/AU2016/000131||STEWART, Penelope, Clair||STEWART, Penelope, Clair|
A new statistical method has been developed to quantify and characterise micro-scale rock damage using rock pore statistics obtained from x-ray micro-tomography of rock core (plug) and rock fragments, in contrast to visible, large-scale "rock mass" damage, which includes dilation and propagation of existing discontinuity planes/macrofractures (e.g. joints, bedding, foliation, faults and shears) on a visible: scale, micro-scale rock damage occurs within the "intact" rock matrix. Whilst engineers have a range of techniques to quantify rock mass damage, micro-scale rock damage methods are limited to qualitative assessments, or indirect correlations. Micro-scale rock damage reduces the "intact" rock mechanical strength properties commonly used in engineering design. Geotechnical, minerals processing, mining, tunnelling and rock mechanics engineering design almost invariably uses the results of standard mechanical testing of intact rock. Micro-scale rock damage affects the pore size distribution and porosity of the rock matrix, and it is these effects, that enable micro-scale rock damage quantification and characterisation using statistical analyses of porosity and rock pore size and volume distributions. Causes of rock damage, include; static stress loads (e.g. due to depth below ground level) and dynamic loads (e.g. blasting, seismicity and rock cutting). Back-analysis of micro-scale rock damage quantification and characterisation enables improved engineering design, particularly in the disciplines of blasting, comminution and seismic risk mitigation.
WO/2016/168883 IMPROVED LOOSE WHEEL NUT INDICATOR AND RESTRAINER||WO||27.10.2016|
||PCT/AU2016/000134||MARCHMONT PTY LIMITED||MASON, Ronald Robert|
An apparatus (10) for visually indicating a loose wheel nut (57) on a wheel of a motor vehicle has a plurality of wheel nut engaging members (12, 14, 16, 18, 20). Each wheel nut engaging member is rotatable with a respective wheel nut to which it is engaged and has a pointer (26) for indicating a start position of the wheel nut engaging member. Any two adjacent wheel nut engaging members of the plurality are interconnected by an elongate member (28) which is resiliently flexible so as to define an endless configuration of spaced apart but interconnected wheel nut engaging members. In use, any loosening rotation of a first wheel nut (57) will cause the engaging member (12) which engages that wheel nut and its pointer (26) to rotate therewith, thereby providing a visual indication of a loosening of that wheel nut.
WO/2016/168884 PLATELET-LIKE PROTEO-MICROPARTICLES AND METHOD OF USING SUCH IN DRUG DELIVERY||WO||27.10.2016|
||PCT/AU2016/000135||ACADEMIA SINICA||HSIEH, Patrick, C., H.|
Proteo-microparticles such as proteoliposomes comprising a microparticle (e.g., a liposome) and platelet membrane proteins, wherein the proteo-microparticles are capable of binding to monocytes, neutrophils, or other circulating blood cells capable of migrating to an injured site. Also provided herein are uses of the proteoliposomes for delivering a therapeutic agent via monocytes to an injured site.
WO/2016/168885 THERAPEUTIC ANTIBODIES AND USES THEREOF||WO||27.10.2016|
||PCT/AU2016/000136||MINOMIC INTERNATIONAL LTD.||WALSH, Bradley|
The present invention relates to therapeutic antibodies for the treatment of cancer, and more specifically, for the treatment of prostate, bladder, and/or pancreatic cancer. An embodiment of the present invention is an anti-glypican- 1 (GPC 1) antibody, which may be conjugated to at least one cytotoxic agent that is toxic to a prostate, bladder, and/or pancreatic cancer cell.
WO/2016/168886 ANIMAL TAG||WO||27.10.2016|
||PCT/AU2016/000138||ENDURO TAGS PTY LTD||STEINFORT, John James|
Tag apparatus for attachment to the ear of an animal including a male member with a stem and a penetrating head for penetrating the ear; a portion that abuts against the hack of the ear and cannot be pulled out of the ear, said portion having an end that is not directed towards the head of the animal when the apparatus is fitted to the ear; such that when the apparatus is fitted to the ear, the apparatus has no overhanging material on which the animal can entangle the tag apparatus on a structure.
WO/2016/168887 ELECTRIC STRINGED INSTRUMENTS||WO||27.10.2016|
||PCT/AU2016/000139||FUSION MUSICTECH IP PTY LTD||McAULD, David|
The present indention provides a stringed musical instrument comprising; a substantially hollow body portion containing an audio system comprising an amplifier; at least one loudspeaker electrically connected to the audio amplifier; an audio interface for electrically connecting to a smart device and a power supply electrically connected to the audio system; a neck sub-assembly including: a neck; playing strings extending lengthwise along the neck; a bridge attached to the neck over which the strings are stretched, and tensioning means by which the strings are held tensioned; and a docking station whereby, in use, a smart device may be removably secured to the instrument and electrically connected to the audio system.
WO/2016/168888 CONDITIONING OF AQUARIUM WATER||WO||27.10.2016|
||PCT/AU2016/000141||PENROSE, Glen||PENROSE, Glen|
A mobile treatment system comprising a mobile or wheelable container able to receive a secondary volume of water separate from the primary volume of water of the aquarium; a water treating apparatus having;a pump mountable to a portion of the mobile container, a first Inlet of the pump able to draw water from a portion of the mobile container, a first outlet of the pump connectable for selectively directing water drawn into the first Inlet back into the mobile container after conditioning of the water, a second inlet able to draw conditioned water from a portion of the mobile container having the conditioned water; a second outlet allowing transfer of the conditioned water from the mobile container to the aquarium, wherein the water is conditioned in the secondary volume of the mobile container at a position remote to the aquarium and Is transportable after conditioning to be adjacent the aquarium and allow transfer of the conditioned water through the second outlet to the aquarium.
WO/2016/168889 POTATO PEELER||WO||27.10.2016|
||PCT/AU2016/000143||BREVILLE PTY LIMITED||THOMAS, Mark|
A potato peeling accessory is adapted to work with a food processor or other means of rotating it. The accessory comprises a working surface on which are formed mechanical abrasion or peeling features.
WO/2016/168890 GENERATION OF MUSCLE-LINEAGE CELLS FROM STEM CELLS||WO||27.10.2016|
||PCT/AU2016/000144||GENEA IP HOLDINGS PTY LTD||SCHMIDT, Uli|
Methods and compositions for producing cells expressing CD56/Pax3, CD56Pax7, and/or Pax3/Pax7 are provided herein. In some instances, the method involves contacting a pluripotent stem cell in an in vitro culture with one compound, or with two or more compounds at the same time, wherein the contacting the pluripotent stem cell in the in vitro culture with one compound, or with two or more compounds at the same time, directly results in generation of cells expressing CD56/Pax3, CD56/Pax7, or Pax3/Pax7. Also provided are methods of using the generated cells. Typically one of the compounds is a wnt pathway activator, such as the GSK3 inhibitor CHIR99021.